<DOC>
	<DOCNO>NCT00515424</DOCNO>
	<brief_summary>This study evaluate tolerability safety RKI983 ophthalmic solution explore effect compound intraocular pressure subject ocular hypertension .</brief_summary>
	<brief_title>Tolerability , Safety Efficacy RKI983 Eye Drops Subjects With Primary Open Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Males female , â‰¥18 year age , primary open angle glaucoma ocular hypertension Females must postmenopausal surgically sterile Other type glaucoma Eye pressure lower surgery A history current eye condition medical problem would prohibit use investigational drug Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>RKI983</keyword>
	<keyword>Primary Open Angle Glaucoma Ocular Hypertension</keyword>
</DOC>